Literature DB >> 23391853

Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage.

Fan Z Caprio1, Matthew B Maas, Neil F Rosenberg, Adam R Kosteva, Richard A Bernstein, Mark J Alberts, Shyam Prabhakaran, Andrew M Naidech.   

Abstract

BACKGROUND AND
PURPOSE: Leukoaraiosis (LA) is associated with dementia, ischemic stroke, and intracerebral hemorrhage (ICH), but there are few data on how LA might impact outcomes after acute ICH. We tested the hypothesis that the severity of LA on magnetic resonance imaging is related to worse functional outcomes after spontaneous ICH.
METHODS: We prospectively identified patients with spontaneous acute ICH. LA was identified on magnetic resonance imaging and its severity was graded using the Fazekas method to include a score for the deep white matter and periventricular regions. Outcomes were obtained at 14 days, 28 days, and 3 months with the modified Rankin Scale (mRS; a validated scale from 0 [no symptoms] to 6 [dead]) and analyzed with multivariate logistic regression.
RESULTS: Higher Fazekas total (periventricular plus deep white matter) score correlated with higher mRS score at 14 days (P=0.02) and 3 months (P=0.02). This relationship was driven by the periventricular score, for which higher score (more severe disease) correlated with higher National Institute of Health Stroke Scale at 14 days (P=0.03), and higher mRS score at 14 days (P<0.001), 28 days (P=0.004), and 3 months (P=0.005). A higher (more severe) Fazekas periventricular score was associated with dependence or death at 3 months (odds ratio, 1.8 per point; 95% confidence interval, 1.02-3.1; P=0.04) after correction for the ICH score.
CONCLUSIONS: Increased LA is an independent predictor of worse functional outcomes in patients after spontaneous ICH. The pathophysiology associating LA with worse outcomes requires further study. These data may improve prognostication and selection for clinical trials.

Entities:  

Mesh:

Year:  2013        PMID: 23391853     DOI: 10.1161/STROKEAHA.112.676890

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

Review 1.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

2.  Impact of Cerebral Small Vessel Disease on Functional Recovery After Intracerebral Hemorrhage.

Authors:  Simone M Uniken Venema; Sandro Marini; Umme K Lena; Andrea Morotti; Michael Jessel; Charles J Moomaw; Christina Kourkoulis; Fernando D Testai; Steven J Kittner; H Bart Brouwers; Michael L James; Daniel Woo; Christopher D Anderson; Jonathan Rosand
Journal:  Stroke       Date:  2019-08-26       Impact factor: 7.914

Review 3.  Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.

Authors:  Mark R Etherton; Ona Wu; Natalia S Rost
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

4.  Association between Serum 25-Hydroxyvitamin D Level and Cognitive Impairment in Patients with White Matter Lesions: A Cross-Sectional Study.

Authors:  Long Wang; Xue-Min Zhao; Xiao-Zheng Yuan; Fu-Yu Wang; Jun Shen; Yu Wang
Journal:  Med Princ Pract       Date:  2020-03-03       Impact factor: 1.927

5.  Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.

Authors:  Cathy R Zhang; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Alison M Ayres; Karen L Furie; Jonathan Rosand; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-06       Impact factor: 2.136

6.  Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials.

Authors:  Jessica R Magid-Bernstein; Yunke Li; Sung-Min Cho; Pirouz J Piran; David J Roh; Ajay Gupta; Ashkan Shoamanesh; Alexander Merkler; Cenai Zhang; Radhika Avadhani; Nataly Montano; Constantino Iadecola; Guido J Falcone; Kevin N Sheth; Adnan I Qureshi; Jonathan Rosand; Joshua Goldstein; Issam Awad; Daniel F Hanley; Hooman Kamel; Wendy C Ziai; Santosh B Murthy
Journal:  Neurology       Date:  2021-12-22       Impact factor: 9.910

7.  White matter disease as a biomarker for long-term cerebrovascular disease and dementia.

Authors:  Aurauma Chutinet; Natalia S Rost
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

8.  Predictors of intraventricular extension of intracerebral hemorrhage confounded by antithrombotic medication exposure.

Authors:  Matthew B Maas; Fan Z Caprio; Neil F Rosenberg; Andrew M Naidech
Journal:  Crit Care Med       Date:  2013-11       Impact factor: 7.598

Review 9.  Resumption of Anticoagulation After Intracranial Hemorrhage.

Authors:  Ivan Rocha Ferreira da Silva; Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

10.  Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke.

Authors:  Mark R Etherton; Ona Wu; Pedro Cougo; Anne-Katrin Giese; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Gregoire Boulouis; Hasan H Karadeli; Arne Lauer; Jonathan Rosand; Karen L Furie; Natalia S Rost
Journal:  Neurology       Date:  2017-04-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.